NHS England said that the launch of the service in 2027 will mean that patients will be seen faster, predicting that it will ...

AbbVie suggested that it may not be able to launch its new ovarian cancer therapy Elahere (mirvetuximab soravtansine) for use ...

Novartis and Boehringer Ingelheim are the latest pharma groups to launch DTC platforms offering cut-price medicines to US ...

In the past, it was easier for pharma to think of launch readiness as a checklist: secure NICE approval, mobilise commercial ...

At this year’s LSX World Congress in Boston, an entire track was devoted to Obesity Science and Innovation, with pharma ...

Already a blockbuster therapy for advanced breast cancer and other indications like gastric cancer, Enhertu made revenues of ...

Investors were spooked by the miss, and shares in Nasdaq-listed Enanta were down around 11%, having risen sharply in ...

LSX World Congress is a meeting place for biotechs, big pharma companies, and investors. Milenko Cicmil is familiar with all three worlds as CEO of Tasca Therapeutics, an investor with Cure Ventures, ...

Walmsley will step down from the board of directors of GSK at the end of the year, and will step down as CEO on 30th ...

AstraZeneca is the latest big pharma group to open up a Direct-To-Consumer (DTC) sales channel in the US, offering three of ...

Antibody specialist Genmab has continued its shift from out-licensing drugs to developing its own medicines with a deal to ...

Earlier this year, PTC Therapeutics and Novartis' experimental therapy for Huntington's, mRNA splicing modifier PTC518 ...